Admedus : Section 708A(5)(e) Notice - Placement

Admedus Ltd

ABN 35 088 221 078

ASX ANNOUNCEMENT

REGISTERED OFFICE:

26 Harris Road Malaga Western Australia 6090

PO Box 6879

East Perth Western Australia 6892

T +61 (0)8 9266 0100

F +61 (0)8 9266 0199

Einfo.au@admedus.com www.admedus.com

5 August 2016

On 5 August 2016 2016, Admedus Limited (Company) issued 30,303,031 fully paid ordinary shares in the capital of the Company (Shares) to sophisticated and institutional investors at a price of $0.33 per Share to raise $10 million (before costs) (Placement). Further details of the Placement are in the Company's announcement lodged with the ASX on 29 July 2016.

The Corporations Act 2001 (Cth) (Corporations Act) restricts the on-sale of securities issued without disclosure, unless the sale is exempt under section 708 or 708A of the Corporations Act. By the Company giving this notice, a sale of the Shares will fall within the exemption in section 708A(5) of the Corporations Act.

The Company hereby gives notice under section 708A(5)(e) of the Corporations Act that:

1. the Company issued the Shares under the Placement without disclosure under Part 6D.2 of the Corporations Act;

2. as at the date of this notice, the Company has complied with:

3. the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

4. section 674 of the Corporations Act;

5. as at the date of this notice, there is no information:

6. that has been excluded from a continuous disclosure notice in accordance with the ASX Listing Rules; and

7. that investors and their professional advisers would reasonably require for the purpose of making an informed assessment of:

8. the assets and liabilities, financial position and performance, profits and losses and prospects of the Company; or

9. the rights and liabilities attaching to the Shares.

10. Yours faithfully

    Mr. Wayne Paterson Chairman and Interim CEO